Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
Osteoarthritis (OA) is a degenerative joint cartilage disease characterized pathologically by osteophytes formation and subchondral bone damage. It leads to pain, stiffness, deformation and even disability in the patients, and increases the risk of comorbidities. As its pathophysiological mechanisms...
Saved in:
Main Authors: | CUI Hanshu, LIU Bin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-01-01
|
Series: | Xiehe Yixue Zazhi |
Subjects: | |
Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0802 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spondyloarthritis and Risk of Malignancy: A Narrative Review on a Still Controversial Issue
by: Ennio Giulio Favalli, et al.
Published: (2024-12-01) -
Primer on the Rheumatic Diseases /
Published: (1993) -
Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial
by: Christopher J. Swearingen, et al.
Published: (2025-01-01) -
Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative review
by: Richard Conway, et al.
Published: (2021-01-01) -
Real life experience of a screening strategy for latent tuberculosis before treatment with biologicals in indian patients with rheumatic diseases
by: Anand N Malaviya, et al.
Published: (2018-01-01)